Nexgel (NXGLW) EBITDA Margin Growth (1y) (2019 - 2025)
Nexgel (NXGLW) EBITDA Margin Growth (1y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 314.00 |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -233.00 |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | -912.00 |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | -306.00 |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -418.00 |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 48.00 |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -171.00 |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -2,130.00 |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 53.00 |
| 10 | Nexgel | 194,000.44 | -994,999.56 | 1.11 Mn | -4,591.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1,576.00 |
| Sep 30, 2025 | 209.00 |
| Jun 30, 2025 | 5,114.00 |
| Mar 31, 2025 | 4,111.00 |
| Dec 31, 2024 | 8,501.00 |
| Sep 30, 2024 | 2,332.00 |
| Jun 30, 2024 | -790.00 |
| Mar 31, 2024 | 7,362.00 |
| Dec 31, 2023 | 3,638.00 |
| Sep 30, 2023 | 13,245.00 |
| Jun 30, 2023 | 6,269.00 |
| Mar 31, 2023 | 6,263.00 |
| Dec 31, 2022 | 1,737.00 |
| Sep 30, 2022 | -48.00 |
| Jun 30, 2022 | 463.00 |
| Mar 31, 2022 | -1,029.00 |
| Dec 31, 2021 | 50,289.00 |
| Sep 30, 2021 | 3,898.00 |
| Jun 30, 2021 | 46,079.00 |
| Mar 31, 2021 | 1,733.00 |